“COMPARISON OF TOTAL ANTIOXIDANT CAPACITY AND CD-4 IN PATIENTS WITH HIV STAGE I AND STAGE IV”, NMSJ, vol. 2, no. 1, pp. 14–21, Aug. 2017, doi: 10.20956/nmsj.v2i1.2255.